Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS

Immunomodulatory agent Teriflunomide has been added to Accord’s pharmaceutical portfolio DURHAM, N.C., March 13, 2023 /PRNewswire/ — Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral medications. The drug is formulated as…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.